Relay Therapeutics, Inc. (RLAY)
14.08
+0.42
(+3.11%)
USD |
NASDAQ |
Jun 09, 16:00
13.81
-0.28
(-1.95%)
After-Hours: 19:14
Relay Therapeutics EPS Diluted (Quarterly) : -0.4075 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Spyre Therapeutics, Inc. | -0.8785 |
| Catalyst Pharmaceuticals, Inc. | 0.5022 |
| Exelixis, Inc. | 0.7873 |
| Insmed, Inc. | -0.7591 |
| United Therapeutics Corp. | 5.824 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -73.29M |
| Revenue (Quarterly) | 3.00M |
| Total Expenses (Quarterly) | 76.29M |
| Enterprise Value | 1.974B |
| Gross Profit Margin (Quarterly) | 83.20% |
| Profit Margin (Quarterly) | -2.44K% |
| Earnings Yield | -11.11% |
| Normalized Earnings Yield | -11.11 |